A NEW STRATEGY FOR DISCONTINUATION OF DUAL ANTIPLATELET THERAPY: REAL SAFETY AND EFFICACY OF 3 MONTHS DUAL ANTIPLATELET THERAPY FOLLOWING ENDEAVOR ZOTAROLIMUS-ELUTING STENT IMPLANTATION

被引：0
|
作者：
Hong, Myeong-Ki [1 ]
Kim, Byeong-Keuk [1 ]
Shin, Dong-Ho [1 ]
Ko, Young-Guk [1 ]
Choi, Donghoon [1 ]
Yoon, Jung-Han [1 ]
Kwon, Hyuck-Moon [1 ]
Jang, Yangsoo [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Seoul 120749, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2012年 / 59卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(12)60008-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E7 / E7
页数：1
相关论文
共 50 条
  • [21] Dual antiplatelet therapy following drug-eluting stent implantation: how long is long enough?
    Ruparelia, Neil
    Chieffo, Alaide
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2015, 13 (06) : 585 - 587
  • [22] Safety and efficacy of dual antiplatelet therapy in transcatheter aortic valve implantation
    Seidel, H.
    Zeus, T.
    Schleicher, M.
    Polzin, A.
    Kelm, M.
    Hohlfeld, T.
    Kirchhoff, E.
    Scharf, R. E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 342 - 342
  • [23] Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation
    Helft, Gerard
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2013, 106 (05) : 271 - 273
  • [24] Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation
    Shin, Dong-Ho
    Hong, Myeong-Ki
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (10) : 1273 - 1285
  • [25] Duration of dual antiplatelet therapy after various drug-eluting stent implantation
    Sharma, Abhishek
    Sharma, Samin K.
    Vallakati, Ajay
    Garg, Akash
    Lavie, Carl J.
    Mukherjee, Debabrata
    Marmur, Jonathan D.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 215 : 157 - 166
  • [26] The risk of bleeding on dual antiplatelet therapy after drug-eluting stent implantation
    Latib, Azeem
    Morici, Nuccia
    Cosgrave, John
    Qasim, Asif
    Airoldi, Flavio
    Brambilla, Nedy
    Bonizzoni, Ermino
    Godino, Cosmo
    Rogacka, Renata
    Tavano, Device
    Romagnoli, Enrico
    Magni, Valerie
    Cheffo, Alaide
    Montorfano, Matteo
    Aranzulla, Tiziana C.
    Bedogni, Francesco
    Castelli, Alfredo
    Briguori, Carlo
    Colombo, Antonio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : B87 - B87
  • [27] The Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
    Price, Matthew J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (13) : 1311 - 1313
  • [28] Dual antiplatelet therapy in the drug-eluting stent era
    Wallentim, Lars
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2008, 10 (0D) : D38 - D44
  • [29] Twelve-Month Clinical Outcomes from the Optimal Duration of Dual Antiplatelet Therapy Following Treatment with Endeavor (Zotarolimus-Eluting Stent) in Real-World Japanese Patients with Coronary Artery Disease (OPERA) Study
    Nakamura, Masato
    Awata, Masaki
    Isshiki, Takaaki
    Kozuma, Ken
    Masatoshi, Miyahara
    Morita, Satoshi
    Nanto, Shinsuke
    Omura, Nobuhiro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : B45 - B46
  • [30] The Safety of 6-Month versus 12-Month Dual Antiplatelet Therapy in Patients Treated with Zotarolimus-Eluting Stent: A Patient-Level Pooled Analysis of Five ENDEAVOR Randomized Trials
    Mehran, Roxana
    Kandzari, David E.
    Mauri, Laura
    Caixeta, Adriano
    Dangas, George
    Negoita, Manuela
    Leon, Martin B.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 168I - 169I
12345